SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bristol Myers Squibb Co. – ‘8-K’ for 3/1/21 – ‘XML’

On:  Thursday, 3/4/21, at 4:30pm ET   ·   For:  3/1/21   ·   Accession #:  1140361-21-7317   ·   File #:  1-01136

Previous ‘8-K’:  ‘8-K’ on 2/23/21 for 2/19/21   ·   Next:  ‘8-K’ on / for 4/29/21   ·   Latest:  ‘8-K’ on 3/18/24 for 3/13/24   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/21  Bristol Myers Squibb Co.          8-K:5,9     3/01/21   11:212K                                   Edgarfilings Ltd.

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     31K 
 7: R1          Document and Entity Information                     HTML     57K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- brhc10021324_8k_htm                 XML     25K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- bmy-20210301_def                 XML     52K 
 4: EX-101.LAB  XBRL Labels -- bmy-20210301_lab                      XML     79K 
 5: EX-101.PRE  XBRL Presentations -- bmy-20210301_pre               XML     56K 
 2: EX-101.SCH  XBRL Schema -- bmy-20210301                          XSD     17K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               16±    22K 
11: ZIP         XBRL Zipped Folder -- 0001140361-21-007317-xbrl      Zip     14K 


‘XML’   —   IDEA XML File — Filing Summary


This Document is an IDEA XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.20.4 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 5 </ContextCount>
<ElementCount> 95 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 4 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 0 </UnitCount>
<MyReports>
<Report instance="brhc10021324_8k.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 000100 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bms.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="8-K" original="brhc10021324_8k.htm"> brhc10021324_8k.htm </File>
<File> bmy-20210301.xsd </File>
<File> bmy-20210301_def.xml </File>
<File> bmy-20210301_lab.xml </File>
<File> bmy-20210301_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy> http://xbrl.sec.gov/dei/2019-01-31 </BaseTaxonomy>
<BaseTaxonomy> http://fasb.org/us-gaap/2019-01-31 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> false </HasCalculationLinkbase>
</FilingSummary>


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  Bristol-Myers Squibb Co.          424B5                  2:1.2M                                   Broadridge Fin’l So… Inc
 2/13/24  Bristol-Myers Squibb Co.          424B2                  1:856K                                   Broadridge Fin’l So… Inc
11/01/23  Bristol-Myers Squibb Co.          424B5                  2:927K                                   Broadridge Fin’l So… Inc
10/30/23  Bristol-Myers Squibb Co.          424B3                  1:818K                                   Broadridge Fin’l So… Inc
 2/17/22  Bristol-Myers Squibb Co.          424B5                  2:878K                                   Broadridge Fin’l So… Inc
 2/15/22  Bristol-Myers Squibb Co.          424B3                  1:789K                                   Broadridge Fin’l So… Inc
12/13/21  Bristol-Myers Squibb Co.          S-3ASR     12/13/21    4:554K                                   Broadridge Fin’l So… Inc
 5/04/21  Bristol-Myers Squibb Co.          S-8         5/04/21    3:81K                                    Broadridge Fin’l So… Inc
 5/04/21  Bristol-Myers Squibb Co.          S-8 POS     5/04/21    3:85K                                    Broadridge Fin’l So… Inc
Top
Filing Submission 0001140361-21-007317   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 3:34:54.2am ET